Overview

The Efficacy of Spironolactone in Patients With Resistant Hypertension

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of the addition of spironolactone to modern blood pressure lowering treatment regimens in patients with resistant hypertension (whose blood pressure is uncontrolled despite three blood pressure lowering drugs)
Phase:
Phase 2
Details
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Collaborator:
University of Sheffield
Treatments:
Spironolactone